LLMs have new probabilistic safety problems that cannot be detected with the current benchmark measures of accuracy such as hallucination, automation bias, demographic unfairness, and privacy. In this chapter, we propose SafeMed, which is a multi-dimensional assessment framework consisting of ten dimensions for clinical safety evaluation in LLMs. SafeMed considers the following aspects: clinical accuracy, hallucination control, robustness, calibration, bias and fairness, ethics, transparency, privacy, safety of human-automation interaction, and operational feasibility. SafeMed is derived based on global standards such as WHO Guidelines for AI Ethics, EU AI Act, and FDA Good Machine Learning Practices (GMLP), and it uses Indonesian regulations as a case study involving ChatGPT-based clinical assistants, Med-PaLM, and RAG. Adversarial testing and human-in-the-loop oversight are proposed as minimum deployment standards. The chapter concludes with a practical evaluation pipeline and governance recommendations for clinicians, administrators, and policymakers.